Home › Funds › HIMENSION CAPITAL (SINGAPORE) PTE. LTD. › MRNA

HIMENSION CAPITAL (SINGAPORE) PTE. LTD. position in MRNA

MODERNA INC · Health Care

HIMENSION CAPITAL (SINGAPORE) PTE. LTD. reported holding 18,536 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.24% of its reported portfolio and ranking #42 among its reported holdings. HIMENSION CAPITAL (SINGAPORE) PTE. LTD. has disclosed MRNA holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)18.54K sh
Reported value held$3.57M
Portfolio Weight0.24%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HIMENSION CAPITAL (SINGAPORE) PTE. LTD.'s MRNA position evolved

HIMENSION CAPITAL (SINGAPORE) PTE. LTD. first disclosed a stake in MRNA in Q3 2023 at 2,553 shares (US$264K). The position peaked in Q3 2026 at 18,536 shares, worth US$3.6M. Across 10 filings, HIMENSION CAPITAL (SINGAPORE) PTE. LTD. increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 18,536 shares valued at US$3.6M — a reduction of -6,682 shares quarter over quarter.. Notable position changes include a 201% increase in Q4 2024 (shares fell 32% over the following quarter), a 112% increase in Q3 2025 (shares rose 14% over the following quarter), a 39% trim in Q1 2026 (shares rose 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.55K $263.70K New
Q3 2024 10.50K $701.45K New
Q4 2024 31.60K $1.31M Add
Q1 2025 33.76K $957.15K Add
Q2 2025 31.47K $868.31K Reduce
Q3 2025 66.67K $1.72M Add
Q4 2025 57.73K $1.70M Reduce
Q1 2026 35.34K $1.80M Reduce
Q2 2026 25.22K $1.77M Reduce
Q3 2026 18.54K $3.57M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 42 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has HIMENSION CAPITAL (SINGAPORE) PTE. LTD. held MRNA?

HIMENSION CAPITAL (SINGAPORE) PTE. LTD. has disclosed MRNA holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is HIMENSION CAPITAL (SINGAPORE) PTE. LTD.'s current position in MRNA?

As of Q3 2026, HIMENSION CAPITAL (SINGAPORE) PTE. LTD. holds 18.54K shares of MRNA (MODERNA INC), valued at $3.57M, representing 0.24% of its reported portfolio and ranking #42.

Has HIMENSION CAPITAL (SINGAPORE) PTE. LTD. been buying or selling MRNA?

In the latest 13F filing (Q3 2026), HIMENSION CAPITAL (SINGAPORE) PTE. LTD. reduced its position in MRNA. The position peaked in Q3 2026 at 18.54K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.